Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Nuclear but Not Cytosolic Phosphoinositide 3-Kinase Beta Has an Essential Function in Cell Survival
Amit Kumar,1,
Javier Redondo-Muñoz,1,
Vicente Perez-García,1,
Isabel Cortes,1
Monica Chagoyen,2, and
Ana C. Carrera1*
Department of Immunology and Oncology,1
Computational Systems Biology Group, Centro Nacional de Biotecnología/CSIC, Cantoblanco, Madrid, Spain2
Received for publication 17 November 2010.
Revision received 17 December 2010.
Accepted for publication 18 February 2011.
Abstract:
Class IA phosphoinositide 3-kinases (PI3Ks) are heterodimericenzymes composed of a p85 regulatory and a p110 catalytic subunitthat induce the formation of 3-polyphosphoinositides, whichmediate cell survival, division, and migration. There are twoubiquitous PI3K isoforms p110α and p110β that havenonredundant functions in embryonic development and cell division.However, whereas p110α concentrates in the cytoplasm,p110β localizes to the nucleus and modulates nuclear processessuch as DNA replication and repair. At present, the structuralfeatures that determine p110β nuclear localization remainunknown. We describe here that association with the p85βregulatory subunit controls p110β nuclear localization.We identified a nuclear localization signal (NLS) in p110βC2 domain that mediates its nuclear entry, as well as a nuclearexport sequence (NES) in p85β. Deletion of p110β inducedapoptosis, and complementation with the cytoplasmic C2-NLS p110βmutant was unable to restore cell survival. These studies showthat p110β NLS and p85β NES regulate p85β/p110βnuclear localization, supporting the idea that nuclear, butnot cytoplasmic, p110β controls cell survival.
* Corresponding author. Mailing address: Department of Immunology and Oncology, Centro Nacional de Biotecnología/CSIC, Darwin 3, Campus de Cantoblanco, Madrid E-28049, Spain. Phone: (34) 91 585-4846. Fax: (34) 91 372-0493. E-mail: acarrera{at}cnb.csic.es.
A.K., J.R.-M., and V.P.-G. contributed equally to this study.
Published ahead of print on 7 March 2011.
The editors suggest the following Related Resources on Science sites:
In Science Signaling
EDITORS' CHOICE
John F. Foley (10 May 2011) Sci. Signal.4 (172), ec133.
[DOI: 10.1126/scisignal.4172ec133] |Abstract »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
PAQR3 Modulates Insulin Signaling by Shunting Phosphoinositide 3-Kinase p110{alpha} to the Golgi Apparatus.
X. Wang, L. Wang, L. Zhu, Y. Pan, F. Xiao, W. Liu, Z. Wang, F. Guo, Y. Liu, W. G. Thomas, et al. (2013)
Diabetes
62, 444-456
|Abstract »|Full Text »|PDF »
Phosphoinositide 3-kinase beta controls replication factor C assembly and function.
J. Redondo-Munoz, M. Josefa Rodriguez, V. Silio, V. Perez-Garcia, J. Maria Valpuesta, and A. C. Carrera (2013)
Nucleic Acids Res.
41, 855-868
|Abstract »|Full Text »|PDF »
Structural Basis for Activation and Inhibition of Class I Phosphoinositide 3-Kinases.
O. Vadas, J. E. Burke, X. Zhang, A. Berndt, and R. L. Williams (2011)
Science Signaling
4, re2
|Abstract »|Full Text »|PDF »